Table 2. Outcomes in Patients Treated With Early Oseltamivir vs Not Treated With Early Oseltamivir in IPTW Analysis.
| Outcome | % (95% CI) | OR (95% CI) | |||
|---|---|---|---|---|---|
| Unadjusted | IPTW model | ||||
| Early oseltamivir | No early oseltamivir | Early oseltamivir | No early oseltamivir | ||
| Hospital LOS, median (IQR), d | 3 (2-5) | 4 (2-8) | 3 (2-5) | 4 (3-9) | 0.52 (0.52-0.53) |
| 7-d Hospital readmission | 3.5 (3.3-3.7) | 4.8 (4.5-5.1) | 3.5 (3.3-3.7) | 4.8 (4.6-5.0) | 0.72 (0.66-0.77) |
| Late ICU transfer | 2.4 (2.2-2.6) | 5.4 (5.1-5.7) | 2.4 (2.2-2.6) | 5.5 (5.2-5.8) | 0.41 (0.37-0.46) |
| In-hospital death or ECMO use | 0.9 (0.8-1.0) | 1.3 (1.1-1.4) | 0.9 (0.8-1.0) | 1.4 (1.3-1.5) | 0.63 (0.54-0.73) |
Abbreviations: ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; IPTW, inverse probability treatment weighting; LOS, length of stay; OR, odds ratio.